Loading company…
Regeners develops stem cell therapies using direct reprogramming technology.
Regeners uses its PDR technology to reprogram cells and develop therapeutic cells, including nerve, heart, and liver cells. Its research focuses on cell regeneration medicine and reversing cellular aging. Founded in 2021, the company is based in Daejeon, South Korea, and is led by CEO Ha Kang Kim. It raised seed funding from TheVentures in October 2022; its partners include Bluepoint and Y’sLetter.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in